Let’s look at the key reasons that are pushing Tango Therapeutics Inc (TNGX) to new highs

On Monday, Tango Therapeutics Inc (NASDAQ: TNGX) was 4.19% up from the session before settling in for the closing price of $3.10. A 52-week range for TNGX has been $2.70 – $13.01.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 132.62%. When this article was written, the company’s average yearly earnings per share was at -11.20%. With a float of $49.52 million, this company’s outstanding shares have now reached $107.41 million.

Let’s determine the extent of company efficiency that accounts for 140 employees. In terms of profitability, gross margin is 95.68%, operating margin of -322.0%, and the pretax margin is -283.95%.

Tango Therapeutics Inc (TNGX) Breakdown of a Key Holders of the stock

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tango Therapeutics Inc stocks. The insider ownership of Tango Therapeutics Inc is 53.90%, while institutional ownership is 48.07%. The most recent insider transaction that took place on Nov 18 ’24, was worth 37,800. In this transaction Director of this company bought 10,000 shares at a rate of $3.78, taking the stock ownership to the 31,250 shares. Before that another transaction happened on Nov 14 ’24, when Company’s Director bought 10,000 for $3.62, making the entire transaction worth $36,200. This insider now owns 21,250 shares in total.

Tango Therapeutics Inc (TNGX) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.38 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -11.20% per share during the next fiscal year.

Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators

You can see what Tango Therapeutics Inc (TNGX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.00.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.17, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.43 in one year’s time.

Technical Analysis of Tango Therapeutics Inc (TNGX)

Looking closely at Tango Therapeutics Inc (NASDAQ: TNGX), its last 5-days average volume was 2.46 million, which is a jump from its year-to-date volume of 1.05 million. As of the previous 9 days, the stock’s Stochastic %D was 53.06%. Additionally, its Average True Range was 0.35.

During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 5.69%, which indicates a significant decrease from 50.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.24% in the past 14 days, which was lower than the 111.53% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $4.39, while its 200-day Moving Average is $7.50. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $3.32. Second resistance stands at $3.42. The third major resistance level sits at $3.57. If the price goes on to break the first support level at $3.07, it is likely to go to the next support level at $2.92. Now, if the price goes above the second support level, the third support stands at $2.82.

Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats

There are 107,418K outstanding shares of the company, which has a market capitalization of 346.96 million. As of now, sales total 36,530 K while income totals -101,740 K. Its latest quarter income was 11,610 K while its last quarter net income were -29,170 K.